Let’s find the next big breakthrough in lupus,
TOGETHER

Lupus Therapeutics is on a “mission possible”: Accelerate drug discovery and diagnostic innovation while advancing health equity, community involvement and ensuring the voices of all people living with lupus are front and center in research.

Let’s find the next big breakthrough in lupus,
TOGETHER

Lupus Therapeutics is on a “mission possible”: Accelerate drug discovery and diagnostic innovation while advancing health equity, community involvement and ensuring the voices of all people living with lupus are front and center in research.

Let’s find the next big breakthrough in lupus,
TOGETHER

Lupus Therapeutics is on a “mission possible”: Accelerate drug discovery and diagnostic innovation while advancing health equity, community involvement and ensuring the voices of all people living with lupus are front in center in research.

Advancing toward a cure

Lupus Therapeutics is the preeminent go-to leader in lupus clinical trials. We partner with biopharmaceutical and biotech companies to identify, develop and deliver potentially life-saving new therapies for lupus through our unique proprietary approach and proven track record of catalyzing, initiating and advancing lupus trials.
Learn more

Equity and Engagement

Innovating Lupus Clinical Research 

Lupus Therapeutics has pioneered programs that aim to address fundamental barriers to clinical research in lupus. We are the only organization with dedicated programs that go beyond one single trial and aim to create better access to clinical research for minorities and underrepresented patient groups. We have introduced novel peer-to-peer support programs and are spearheading initiatives to standardize outcomes measures for the global research community.

Learn more

The LuCIN difference

The Lupus Clinical Investigators Network or LuCIN, developed and overseen by Lupus Therapeutics, is a lupus clinical trials network comprised of the most reputable academic research medical centers throughout North America. LuCIN leverages the expertise of more than 200 experienced clinician-scientists focused on lupus research and treating more than 25,000 people living with lupus.

Learn more

Acceleration in action case study

Eli Lilly, a world leader in immunology, engaged the full suite of Lupus Therapeutics services to help prioritize its pipeline and quickly advance candidates into human trials. 

View the case study

Acceleration in action case study

Eli Lilly, a world leader in immunology, engaged the full suite of Lupus Therapeutics services to help prioritize its pipeline and quickly advance candidates into human trials. 

View the case study

Discover our solutions

A research innovation accelerator dedicated to improving lupus treatments and advancing research toward a cure, only Lupus Therapeutics has a track record of successfully collaborating with the top global pharmaceutical companies engaged in lupus clinical studies.

Learn more

Discover our solutions

A research innovation accelerator dedicated to improving lupus treatments and advancing research toward a cure, only Lupus Therapeutics has a track record of successfully collaborating with the top global pharmaceutical companies engaged in lupus clinical studies.

Learn more

Discover our solutions

A research innovation accelerator dedicated to improving lupus treatments and advancing research toward a cure, only Lupus Therapeutics has a track record of successfully collaborating with the top 13 global pharmaceutical companies engaged in lupus clinical studies.

Learn more